| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 29.225 | 64.661 | 79.760 | 84.430 | 123.025 | 109.795 |
| Total Income - EUR | - | - | - | - | 45.857 | 77.138 | 84.571 | 84.433 | 123.034 | 109.801 |
| Total Expenses - EUR | - | - | - | - | 44.432 | 50.524 | 62.812 | 76.159 | 95.131 | 120.455 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.425 | 26.614 | 21.759 | 8.274 | 27.903 | -10.655 |
| Net Profit/Loss - EUR | - | - | - | - | 1.132 | 26.171 | 21.074 | 7.590 | 27.119 | -13.390 |
| Employees | - | - | - | - | 5 | 7 | 9 | 10 | 11 | 11 |
Check the financial reports for the company - Pedromed2020 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 11.323 | 14.906 | 12.277 | 13.885 | 11.288 | 8.684 |
| Current Assets | - | - | - | - | 20.606 | 34.857 | 50.311 | 24.810 | 53.175 | 36.595 |
| Inventories | - | - | - | - | 1 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 871 | 4.037 | 841 | 5.389 | 21.381 | 17.428 |
| Cash | - | - | - | - | 19.734 | 30.821 | 49.470 | 19.421 | 31.794 | 19.167 |
| Shareholders Funds | - | - | - | - | 1.175 | 27.324 | 47.792 | 24.040 | 51.086 | 37.411 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 12.465 | 11.176 | 5.745 | 7.264 | 7.690 | 4.754 |
| Income in Advance | - | - | - | - | 18.288 | 11.263 | 9.051 | 7.392 | 5.687 | 3.114 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Pedromed2020 S.r.l.